FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

11984007: Alfacalcidol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2618971013 Alfacalcidol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3664647014 Alfacalcidol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3721858016 1, hydroxy cholecalciferol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
375131000195114 alfacalcidolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
42871000188117 Alfacalcidol fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
398531000274116 Alphacalcidol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alfacalcidol Is a Vitamin D and/or vitamin D derivative false Inferred relationship Some
Alfacalcidol Is a Vitamin D3 metabolite false Inferred relationship Some
Alfacalcidol Is a Vitamin D analogue true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing alfacalcidol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 250 nanogram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Alfacalcidol 1 microgram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Alfacalcidol 2mcg/mL injection solution 0.5mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Alfacalcidol 2mcg/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Alfacalcidol 500 nanogram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some
Alfacalcidol 250 nanogram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some 1
Alfacalcidol 250 nanogram oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 1 microgram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some 1
Alfacalcidol 1 microgram oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 500 nanogram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alfacalcidol Inferred relationship Some 1
Alfacalcidol 500 nanogram oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alfacalcidol Inferred relationship Some 1
Product containing alfacalcidol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 250 nanogram oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 1 microgram oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alfacalcidol Inferred relationship Some 1
Alfacalcidol 500 nanogram oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alfacalcidol Inferred relationship Some 1
Product containing alfacalcidol in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release oral drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 1 microgram/0.5 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 1 microgram/0.5 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alfacalcidol Inferred relationship Some 1
Alfacalcidol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Alfacalcidol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Product containing only alfacalcidol in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alfacalcidol Inferred relationship Some 1
Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alfacalcidol Inferred relationship Some 1

This concept is not in any reference sets

Back to Start